Most drug candidates fail, costing companies and ultimately everyone who uses pharmacologics untold billions. This is a panel discussion of major powerhouses in therapeutics who can explain exactly what goes wrong--or right--and why.
You must sign up at http://nycbio-clinicaltrialsevent.eventbrite.com to come. Full bios there.
Drs. Jules Mitchel (President of Target Health), Terry F. Plasse (Plasse Associates) and Risa Shapiro (Global Program Team Director, Oncology Clinical Development, Novartis) will discuss the latest advances in the development of modern therapies and in particular the translation to clinical trials. Topics for discussion include an overview of the clinical development process, case studies of global clinical trials, approaches to reduce clinical timeline, drug attrition rates, FDA interactions and Clinical Research Management. We’ll learn from their experience, success and failures, as they provide insight into the process and what it takes for a candidate to make it through pre-clinical stages. Panelists will also provide invaluable advice to the biotech community on careers available in this field. Questions and networking will follow the discussion. Refreshments provided.
Join a power-packed audience of those people who make biotech happen including CSOs, CEOs, partners, directors, scientists, entrepreneurs, IP attorneys and founders in addition to lots of younger people finishing PhDs/MDs/etc. and/or their postdoc servitudes. In other words, the perfect mix to make biotechs.